A small group of subjects with NASH had decreases in markers of hepatic fibrosis including TGF-β1, less activation of stellate cells, and histological improvement on liver biopsy after treatment with ARBs [41, 42]. Here, TGFB1 is linked to Hepatic fibrosis.